- Published on
Pharmacology - Imatinib
Inhibiting protein kinases is a significant function of imatinib in cancers such as chronic myeloid leukemia.
Administered orally and absorbed fully.
Medical Application
Various types of leukemia, including chronic myeloid, acute lymphoblastic, gastrointestinal stromal tumors, chronic eosinophilic, and myeloproliferative ailments.
Potential Side Effects
gastrointestinal issues, nausea, vomiting, diarrhea, redness, swelling, difficulty breathing, paresthesia, joint pain, conjunctivitis, photosensitivity, vertigo, perspiration, rash, and abdominal pain.
Inhibiting protein kinases is a significant function of imatinib in cancers such as chronic myeloid leukemia.
Administered orally and absorbed fully.
Medical Application
Various types of leukemia, including chronic myeloid, acute lymphoblastic, gastrointestinal stromal tumors, chronic eosinophilic, and myeloproliferative ailments.
Potential Side Effects
gastrointestinal issues, nausea, vomiting, diarrhea, redness, swelling, difficulty breathing, paresthesia, joint pain, conjunctivitis, photosensitivity, vertigo, perspiration, rash, and abdominal pain.
0 Comments
